NASDAQ$HCAT
Health Catalyst Inc · Q4 2019 earnings
Q4 2019 earnings · · Investor relations
Briefing
Health Catalyst had an exceptional Q4 2019, achieving strong results across all areas of its business and exceeding the midpoint of its guidance for the quarter.
Health Catalyst reported strong Q4 2019 results, exceeding the midpoint of its guidance. The company's team member engagement scores were in the 99th percentile, marking the highest achievement in the company's history.
- Technology revenue was $22.58 million, a 20% year-over-year increase.
- Professional services revenue was $20.92 million, a 21% year-over-year increase.
- Total revenue was $43.50 million, a 21% year-over-year increase.
- Adjusted EBITDA was $(6.49) million, a 31% year-over-year improvement.
Headline financials
Revenue & EPS history
Health Catalyst · Revenue · Quarterly
$43.5M
Revenue by segment
Health Catalyst · $43.5M total across 2 segments · Q4 2019
- Technology$22.6M+20.3%51.9%
- Professional Services$20.9M+20.8%48.1%
Forward guidance
For the first-quarter of 2020, Health Catalyst expects total revenue between $42.0 million and $45.0 million, and Adjusted EBITDA between $(8.5) million and $(6.5) million. For the full-year of 2020, the company expects total revenue between $185.0 million and $188.0 million, and Adjusted EBITDA between $(23.5) million and $(20.5) million.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q4 2019
-3.1%
Avg return
Earnings day
-3.9%
Avg return
5 days after
-4.0%
Avg return
30 days after
41%
11 / 27 earnings
Positive
+27.3%
Q2 2024
Best reaction
-36.6%
Q2 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -9.9% | -21.7% | +4.6% | |
| Q4 2025 | -26.3% | -35.2% | -44.4% | |
| Q3 2025 | -5.6% | -20.5% | -10.2% | |
| Q1 2025 | +5.3% | +8.1% | +3.3% | |
| Q4 2024 | -11.1% | -8.5% | -7.9% | |
| Q3 2024 | +14.2% | +7.2% | +7.6% | |
| Q2 2024 | +27.3% | +7.3% | +22.9% | |
| Q1 2024 | -3.6% | +2.9% | -2.3% | |
| Q4 2023 | -14.7% | -8.9% | -14.4% | |
| Q3 2023 | +5.1% | -0.4% | +5.3% | |
| Q2 2023 | -8.0% | -5.0% | -12.4% | |
| Q1 2023 | -18.9% | -14.8% | -4.3% | |
| Q4 2022 | +7.3% | +5.8% | -14.8% | |
| Q3 2022 | +16.2% | +42.9% | +59.2% | |
| Q2 2022 | -36.6% | -34.7% | -35.9% | |
| Q1 2022 | -2.6% | +24.6% | +10.5% | |
| Q4 2021 | +1.5% | -7.1% | -3.7% | |
| Q3 2021 | -6.2% | -6.1% | -26.9% | |
| Q2 2021 | +1.5% | -2.3% | -2.8% | |
| Q1 2021 | -2.3% | -8.6% | -2.4% | |
| Q4 2020 | +0.6% | +0.1% | -2.1% | |
| Q3 2020 | -0.2% | -3.5% | +6.2% | |
| Q2 2020 | -7.2% | -10.9% | -3.4% | |
| Q1 2020 | -1.9% | -0.5% | -5.0% | |
| Q4 2019 | +1.3% | -5.8% | -20.1% | |
| Q3 2019 | +1.9% | -0.8% | -1.1% | |
| Q2 2019 | -11.5% | -7.8% | -13.1% | |
| Q4 2018 | — | — | — | |
| Q3 2018 | — | — | — | |
| Q2 2018 | — | — | — | |
| Q1 2018 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro